These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 29465696)
21. Where are people being tested for anti-HCV in England? Results from sentinel laboratory surveillance. Brant LJ; Hurrelle M; Balogun MA; Klapper P; Ramsay ME; J Viral Hepat; 2008 Oct; 15(10):729-39. PubMed ID: 18637078 [TBL] [Abstract][Full Text] [Related]
22. Integrating Routine HCV Testing in Primary Care: Lessons Learned from Five Federally Qualified Health Centers in Philadelphia, Pennsylvania, 2012-2014. Coyle C; Kwakwa H; Viner K Public Health Rep; 2016; 131 Suppl 2(Suppl 2):65-73. PubMed ID: 27168664 [TBL] [Abstract][Full Text] [Related]
23. Limited spread of hepatitis C among HIV-negative men who have sex with men in Stockholm, Sweden. Blaxhult A; Samuelson A; Ask R; Hökeberg I Int J STD AIDS; 2014 Jun; 25(7):493-5. PubMed ID: 24352124 [TBL] [Abstract][Full Text] [Related]
24. Identification and Linkage to Care of HCV-Infected Persons in Five Health Centers - Philadelphia, Pennsylvania, 2012-2014. Coyle C; Viner K; Hughes E; Kwakwa H; Zibbell JE; Vellozzi C; Holtzman D; MMWR Morb Mortal Wkly Rep; 2015 May; 64(17):459-63. PubMed ID: 25950252 [TBL] [Abstract][Full Text] [Related]
25. Integrating hepatitis, STD, and HIV services into a drug rehabilitation program. Gunn RA; Lee MA; Callahan DB; Gonzales P; Murray PJ; Margolis HS Am J Prev Med; 2005 Jul; 29(1):27-33. PubMed ID: 15958248 [TBL] [Abstract][Full Text] [Related]
26. Testing for HCV: the first step in preventing disease transmission and improving health outcomes for HCV-infected individuals. Ward JW Antivir Ther; 2012; 17(7 Pt B):1397-401. PubMed ID: 23321543 [TBL] [Abstract][Full Text] [Related]
27. Risk factors and seroprevalence of hepatitis C virus antibody among blood donors in Lagos. Balogun TM; Akinsete I; Durosinmi MA Niger Postgrad Med J; 2012 Mar; 19(1):36-9. PubMed ID: 22430600 [TBL] [Abstract][Full Text] [Related]
28. Improving Screening Methods for Hepatitis C Among People Who Inject Drugs: Findings from the HepTLC Initiative, 2012-2014. Blackburn NA; Patel RC; Zibbell JE Public Health Rep; 2016; 131 Suppl 2(Suppl 2):91-7. PubMed ID: 27168667 [TBL] [Abstract][Full Text] [Related]
29. [Investigations on hepatitis C virus infection among heterosexuals with multiple partners and patients with sexually transmitted diseases]. Ding J Zhonghua Liu Xing Bing Xue Za Zhi; 1993 Aug; 14(4):231-3. PubMed ID: 7511486 [TBL] [Abstract][Full Text] [Related]
30. Risk factors for hepatitis C infection among sexually transmitted disease-infected, inner city obstetric patients. Choy Y; Gittens-Williams L; Apuzzio J; Skurnick J; Zollicoffer C; McGovern PG Infect Dis Obstet Gynecol; 2003; 11(4):191-8. PubMed ID: 15108864 [TBL] [Abstract][Full Text] [Related]
31. Public health clinic-based hepatitis C testing and linkage to care in Baltimore. Falade-Nwulia O; Mehta SH; Lasola J; Latkin C; Niculescu A; O'Connor C; Chaulk P; Ghanem K; Page KR; Sulkowski MS; Thomas DL J Viral Hepat; 2016 May; 23(5):366-74. PubMed ID: 26840570 [TBL] [Abstract][Full Text] [Related]
32. Dual positivity of hepatitis B surface antigen and anti-hepatitis C virus antibody and associated factors among apparently healthy patients of Ekiti State, Nigeria. Oje OJ; Sule WF; Famurewa D Viral Immunol; 2012 Dec; 25(6):448-55. PubMed ID: 23171358 [TBL] [Abstract][Full Text] [Related]
33. Burden of hepatitis C virus disease and access to hepatitis C virus services in people who inject drugs in India: a cross-sectional study. Solomon SS; Mehta SH; Srikrishnan AK; Solomon S; McFall AM; Laeyendecker O; Celentano DD; Iqbal SH; Anand S; Vasudevan CK; Saravanan S; Lucas GM; Kumar MS; Sulkowski MS; Quinn TC Lancet Infect Dis; 2015 Jan; 15(1):36-45. PubMed ID: 25486851 [TBL] [Abstract][Full Text] [Related]
34. Hepatitis C virus infection in the 1945-1965 birth cohort (baby boomers) in a large urban ED. Allison WE; Chiang W; Rubin A; O'Donnell L; Saldivar MA; Maurantonio M; Dela Cruz J; Duvidovich S; Carmody E Am J Emerg Med; 2016 Apr; 34(4):697-701. PubMed ID: 26809931 [TBL] [Abstract][Full Text] [Related]
35. The Hepatitis Testing and Linkage-to-Care Data Review Process: An Approach to Ensuring the Quality of Program Data. Mezzo JL; Lamia TL; Danelski LL; Schipani AM; Stokes SA; Jacobs-Ware ED Public Health Rep; 2016; 131 Suppl 2(Suppl 2):44-8. PubMed ID: 27168661 [TBL] [Abstract][Full Text] [Related]
36. Human immunodeficiency virus and hepatitis C virus infections among patients attending sexually transmitted disease clinics, Regional 2, Thailand. Luksamijarulkul P; Khemnak P; Pacheun O Asia Pac J Public Health; 2000; 12(1):41-5. PubMed ID: 11200218 [TBL] [Abstract][Full Text] [Related]
37. Performance of premarket rapid hepatitis C virus antibody assays in 4 national human immunodeficiency virus behavioral surveillance system sites. Smith BD; Teshale E; Jewett A; Weinbaum CM; Neaigus A; Hagan H; Jenness SM; Melville SK; Burt R; Thiede H; Al-Tayyib A; Pannala PR; Miles IW; Oster AM; Smith A; Finlayson T; Bowles KE; Dinenno EA Clin Infect Dis; 2011 Oct; 53(8):780-6. PubMed ID: 21921221 [TBL] [Abstract][Full Text] [Related]
38. Sero-surveillance of HIV, HBV and HCV infections in antenatal and STD clinic attendees. Ganju SA; Goel A J Commun Dis; 2004 Mar; 36(1):60-2. PubMed ID: 16295688 [No Abstract] [Full Text] [Related]
39. Seroprevalence of multiple sexually transmitted infections among antenatal clinic attendees in Gondar Health Center, northwest Ethiopia. Tiruneh M Ethiop Med J; 2008 Oct; 46(4):359-66. PubMed ID: 19271400 [TBL] [Abstract][Full Text] [Related]
40. Point-of-care testing for HCV infection: recent advances and implications for alternative screening. Parisi MR; Soldini L; Vidoni G; Mabellini C; Belloni T; Brignolo L; Negri S; Schlusnus K; Dorigatti F; Lazzarin A New Microbiol; 2014 Oct; 37(4):449-57. PubMed ID: 25387283 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]